Sterling Investment Advisors, Ltd. Organon & Co. Transaction History

Sterling Investment Advisors, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$31.66 - $38.9 $4,749 - $5,835	-150 Reduced 7.55%	1,836 $62,000
Q1 2022 May 03, 2022	SELL	$30.45 - $39.36 $2,253 - $2,912	-74 Reduced 3.59%	1,986 $69,000
Q4 2021 Feb 02, 2022	SELL	$28.67 - $37.13 $458 - $594	-16 Reduced 0.77%	2,060 $63,000
Q3 2021 Nov 09, 2021	SELL	$28.63 - $35.64 $8,932 - $11,119	-312 Reduced 13.07%	2,076 $68,000
Q2 2021 Jul 29, 2021	BUY	$28.45 - $38.0 $67,938 - $90,744	2,388 New	2,388 $72,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.